Kestra Medical Technologies Ltd’s filing revealed that its Director COHEN RAYMOND W acquired Company’s shares for reported $0.29 million on Mar 07 ’25. In the deal valued at $17.00 per share,17,000 shares were bought. As a result of this transaction, COHEN RAYMOND W now holds 29,994 shares worth roughly $0.7 million.
Wolfe Research initiated its Kestra Medical Technologies Ltd [KMTS] rating to an Outperform in a research note published on March 31, 2025; the price target was $29. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late March with a ‘”an Overweight”‘ rating. Stifel began covering KMTS with “Buy” recommendation on March 31, 2025. Piper Sandler started covering the stock on March 31, 2025. It rated KMTS as “an Overweight”.
Price Performance Review of KMTS
On Tuesday, Kestra Medical Technologies Ltd [NASDAQ:KMTS] saw its stock jump 2.29% to $23.2. Over the last five days, the stock has gained 29.83%. Nevertheless, the stocks have risen 6.23% over the past one year.
How much short interest is there in Kestra Medical Technologies Ltd?
A steep rise in short interest was recorded in Kestra Medical Technologies Ltd stocks on 2025-08-29, growing by 0.17 million shares to a total of 2.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 2.07 million shares. There was a rise of 7.38%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 31, 2025 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $24 price target.
